Normalization of auditory physiology by cigarette smoking in schizophrenic patients - PubMed (original) (raw)
Normalization of auditory physiology by cigarette smoking in schizophrenic patients
L E Adler et al. Am J Psychiatry. 1993 Dec.
Abstract
Objective: Because many schizophrenic patients are heavy smokers, it has been suggested that nicotine normalizes some neuronal deficit involved in their illness. Schizophrenic subjects have various difficulties with maintenance of attention and selective processing of sensory information. One defect in sensory gating in schizophrenia has been characterized by recording auditory evoked potentials. Most normal subjects have a decrease in the evoked response to the second of two closely paired stimuli, whereas most schizophrenic subjects do not. The aim of this study was to determine whether smoking normalizes this deficit in auditory sensory gating in schizophrenia.
Method: Changes in auditory sensory gating in response to smoking cigarettes were studied in 10 smokers without psychiatric illness and 10 schizophrenic smokers. Both groups were asked to abstain from smoking from 11:00 p.m. until 8:00 a.m. the next morning, when their auditory evoked responses to pairs of clicks were recorded. The ability to gate sensory information is reflected in a decrease in the P50 wave amplitude in response to the second of the two stimuli. After baseline recordings, the subjects smoked as much as they wished, and then two postsmoking recordings were performed.
Results: The schizophrenic patients had a marked but brief improvement in P50 auditory gating immediately after smoking, whereas P50 gating for the normal smokers was slightly impaired.
Conclusions: This study suggests that cigarette smoking can transiently normalize the impairment of auditory sensory gating in schizophrenic patients.
Similar articles
- Differential sensory gating functions between smokers and non-smokers among drug-naive first episode schizophrenic patients.
Chen XS, Li CB, Smith RC, Xiao ZP, Wang JJ. Chen XS, et al. Psychiatry Res. 2011 Aug 15;188(3):327-33. doi: 10.1016/j.psychres.2010.12.009. Epub 2011 Jan 8. Psychiatry Res. 2011. PMID: 21216472 - Auditory sensory gating and catecholamine metabolism in schizophrenic and normal subjects.
Waldo M, Gerhardt G, Baker N, Drebing C, Adler L, Freedman R. Waldo M, et al. Psychiatry Res. 1992 Oct;44(1):21-32. doi: 10.1016/0165-1781(92)90066-c. Psychiatry Res. 1992. PMID: 1461944 - Schizophrenia, sensory gating, and nicotinic receptors.
Adler LE, Olincy A, Waldo M, Harris JG, Griffith J, Stevens K, Flach K, Nagamoto H, Bickford P, Leonard S, Freedman R. Adler LE, et al. Schizophr Bull. 1998;24(2):189-202. doi: 10.1093/oxfordjournals.schbul.a033320. Schizophr Bull. 1998. PMID: 9613620 Review. - [P50 sensory gating disorders of auditory evoked potentials (AEP) in persons with schizophrenia].
Wegrzyn J. Wegrzyn J. Psychiatr Pol. 2004 Sep-Oct;38(5):833-45. Psychiatr Pol. 2004. PMID: 15523930 Review. Polish.
Cited by
- Mouse models for studying genetic influences on factors determining smoking cessation success in humans.
Hall FS, Markou A, Levin ED, Uhl GR. Hall FS, et al. Ann N Y Acad Sci. 2012 Feb;1248:39-70. doi: 10.1111/j.1749-6632.2011.06415.x. Ann N Y Acad Sci. 2012. PMID: 22304675 Free PMC article. Review. - Inhibitory control of sensory gating in a computer model of the CA3 region of the hippocampus.
Moxon KA, Gerhardt GA, Gulinello M, Adler LE. Moxon KA, et al. Biol Cybern. 2003 Apr;88(4):247-64. doi: 10.1007/s00422-002-0373-7. Biol Cybern. 2003. PMID: 12690484 Free PMC article. - Regulation of a novel alphaN-catenin splice variant in schizophrenic smokers.
Mexal S, Berger R, Pearce L, Barton A, Logel J, Adams CE, Ross RG, Freedman R, Leonard S. Mexal S, et al. Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 5;147B(6):759-68. doi: 10.1002/ajmg.b.30679. Am J Med Genet B Neuropsychiatr Genet. 2008. PMID: 18163523 Free PMC article. - Cognitive performance and cigarette smoking in first-episode psychosis.
Zabala A, Eguiluz JI, Segarra R, Enjuto S, Ezcurra J, González Pinto A, Gutiérrez M. Zabala A, et al. Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):65-71. doi: 10.1007/s00406-008-0835-6. Epub 2008 Jun 26. Eur Arch Psychiatry Clin Neurosci. 2009. PMID: 18584231 - Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia.
Tizabi Y. Tizabi Y. Neurotox Res. 2007 Dec;12(4):233-46. doi: 10.1007/BF03033907. Neurotox Res. 2007. PMID: 18201951 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials